Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONSERV-2
2008-008354-23Phase 2Completed
- Sponsor
- Cubist Pharmaceuticals, Inc.
- Start
- Mar 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in perioperative bleeding comparing Ecallantide arm with Tranexamic acid arm (2 arms). Primary endpoint: Relative efficacy in reduction of blood loss. Started Mar 2009; status: completed.
02
Drugs
ecallantidetranexamic acid
03
Conditions
perioperative bleeding
Beyond the preview
Go deeper on 2008-008354-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008354-23.